Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXDX | NUVL | HALO | ||
| Company | Prometheus Biosciences Inc | Nuvalent Cl A | Halozyme Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 199.68 | 123.57 | 77.85 | ||
| High | 199.98 | 123.80 | 79.51 | ||
| Low | 199.60 | 123.57 | 77.54 | ||
| Latest | 199.92 | 123.73 | 79.45 | ||
| Change | +0.18 | +0.13 | +2.44 | ||
| % Change | +0.09% | +0.11% | +3.17% | ||
| Volume | 1,860,600 | 1,297,500 | 1,566,200 | ||
| 20-Day Average Volume | 1,174,595 | 5,255,735 | 1,855,460 | ||
| Previous Close | 199.74 | 123.60 | 77.01 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 198.02 | 118.61 | 72.17 | ||
| 20-Day Raw Stochastic | 99.23% | 99.81% | 99.52% | ||
| 20-Day Relative Strength | 81.45 | 64.08 | 68.01 | ||
| Weighted Alpha | +110.70 | +32.41 | +44.94 | ||
| Today's Opinion | 100% Buy | 100% Buy | 72% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 8% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.47% since 06/08/23 | +0.16% since 06/25/26 | +9.38% since 06/25/26 | ||
| Low | 198.91 on 06/09/23 | 123.43 on 06/30/26 | 72.71 on 06/26/26 | ||
| High | 199.98 on 06/15/23 | 123.80 on 07/02/26 | 79.51 on 07/02/26 | ||
| 1-Month | |||||
| %Chg | +2.82% since 05/15/23 | +35.45% since 06/02/26 | +19.87% since 06/02/26 | ||
| Low | 189.76 on 05/16/23 | 87.30 on 06/08/26 | 66.00 on 06/03/26 | ||
| High | 199.98 on 06/15/23 | 123.80 on 07/02/26 | 79.51 on 07/02/26 | ||
| 3-Month | |||||
| %Chg | +72.97% since 03/15/23 | +17.36% since 04/02/26 | +23.20% since 04/02/26 | ||
| Low | 104.55 on 03/30/23 | 87.30 on 06/08/26 | 62.27 on 04/07/26 | ||
| High | 199.98 on 06/15/23 | 123.80 on 07/02/26 | 79.51 on 07/02/26 | ||
| 6-Month | |||||
| %Chg | +85.68% since 12/15/22 | +22.70% since 01/02/26 | +13.00% since 01/02/26 | ||
| Low | 103.33 on 01/06/23 | 87.30 on 06/08/26 | 61.33 on 03/27/26 | ||
| High | 199.98 on 06/15/23 | 123.80 on 07/02/26 | 82.22 on 02/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,558,772 | 9,774,423 | 9,423,802 | ||
| Shares Outstanding, K | 47,813 | 78,998 | 118,613 | ||
| Annual Sales | 6,810,000 | 0 | 1,396,610,000 | ||
| Annual Net Income | -141,750,000 | -425,380,000 | 316,890,000 | ||
| Last Quarter Sales | 1,110,000 | 0 | 376,710,000 | ||
| Last Quarter Net Income | -40,880,000 | -109,280,000 | 150,050,000 | ||
| 60-Month Beta | -0.49 | 1.14 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.86 on 05/09/23 | -1.39 on 05/07/26 | 1.60 on 05/11/26 | ||
| Earnings Date | 08/10/23 | 08/06/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 18.21 | ||